$MKL — BUY 📊

$MKL — BUY 📊 Markel Group Inc. engages in the insurance business in the United States, the United Kingdom, Bermuda, Germany, rest of the European Union, Canada, and the Asia Pacific. 🎯 Q1 FY26 | Rev $4B | EPS $23.55 vs $26.34 🔴 💡 Consensus likely extrapolates the weak quarter into a permanently lower earnings trajectory. Our variant view is that MKL's diversified insurance and investment operations will generate $110-130 in annual EPS over the cycle, while the stock is pricing in ~$95-100. 📉 Reward/Risk: 2.89:1 🏢 Business Quality: 8/10 - Markel is a well-managed specialty insurer with a long track record of underwriting discipline and superior investment returns, akin to a mini-Berkshire. Its combined ratio typically runs in the low-to-mid 90s, and the investment portfolio benefits from a long-duration equity compounder. 📊 Our read: BUY. Full analysis → https://stockduty.xyz/s/MKL0617

Markel Group Inc. engages in the insurance business in the United States, the United Kingdom, Bermuda, Germany, rest of the European Union, Canada, and the Asia Pacific.